Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06593522
Title A Phase 2 Study of AMG 193 in Participants With MTAP-deleted Advanced NSCLC
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Amgen
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN | AUS

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010 United States Details
City of Hope Orange County Lennar Foundation Cancer Center Duarte California 91010 United States Details
Valkyrie Clinical Trials Los Angeles California 90067 United States Details
University of California Los Angeles Los Angeles California 90095 United States Details
Eastern Connecticut Hematology and Oncology Associates Norwich Connecticut 06360 United States Details
Cancer and Hematology Centers of Western Michigan Grand Rapids Michigan 49503 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
GenesisCare -North Shore Oncology St Leonards New South Wales 2065 Australia Details
Calvary Mater Newcastle Hospital Waratah New South Wales 2298 Australia Details
McGill University Health Centre Glen Site Montreal Quebec H4A 3J1 Canada Details
National Cancer Centre Singapore Singapore 168583 Singapore Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field